BioSpace News Archive

PepGen Inc. (“PepGen”), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results for the first quarter ended March 31, 2022.

Sanofi Canada is pleased to award four, $50,000 Sanofi Biogenius Canada Grants to public high schools from across the country to help provide better access to hands-on STEM (science, technology, engineering and math) learning by updating lab equipment, launching new science programs and taking science education to the next level.

Evofem Biosciences, Inc., (Nasdaq: EVFM) today announced results of a post hoc analysis of the registrational Phase 3 AMPOWER trial investigating the ability of Phexxi® (lactic acid, citric acid, and potassium bitartrate) to prevent pregnancy.

Aerami Therapeutics, Inc. today announces the appointment of Lisa Yañez as chief operating officer.

Skylight Health Group Inc. (NASDAQ:SLHG; TSXV:SLHG) (“Skylight Health” or the “Company”), a multi-state primary care management group in the United States, today announces the appointment of Farooq Akhter as Interim Chief Financial Officer (CFO), effective June 15, 2022.

Vivera Pharmaceuticals is pleased to welcome Fabio Macciardi, M.D., Ph.D., to its Advisory Board as Neurogenetics Scientific Advisor to the Company’s Biosciences Division.

BioAgilytix Labs, LLC today announces the appointment, effective immediately, of Euan Menzies as Chairman and CEO. Jim Datin is retiring from his executive management role.

Aerin Medical Inc. a company dedicated to providing Ear, Nose and Throat (ENT) physicians with non-invasive solutions for the treatment of chronic nasal conditions, today announced it has recently closed a $60 million equity financing.

Welldoc Granted 31st Patent for First-in-Class Chronic Care Platform.

NasoNeb®, Inc. is proud to announce their integration with Monaghan Medical Corporation in Plattsburgh, New York.